• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Mesa Biotech

Thermo Fisher completes Mesa Biotech acquisition

February 26, 2021 By Sean Whooley

Thermo Fisher Scientific (NYSE:TMO) announced today that it completed its previously announced acquisition of Mesa Biotech. Last month, Waltham, Mass.-based Thermo Fisher announced its agreement to buy the point-of-care molecular diagnostic developer for approximately $450 million in cash. Mesa Biotech will become part of Thermo Fisher’s life sciences solution segment and is expected to bring […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Mergers & Acquisitions Tagged With: coronavirus, COVID-19, Mesa Biotech, Thermo Fisher Scientific

MedTech 100 roundup: Another peak for the industry

January 25, 2021 By Sean Whooley

Medtech stocks have been on the rise in 2021, and the past week saw the trend continue with yet another all-time best mark. MassDevice‘s MedTech 100 index reached 107.4 points on Jan. 20, topping the all-time best of 106.81 points set on Jan. 8. That mark represents a 16% jump from the pre-pandemic high of 92.32 […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, Amazon, Bardy Diagnostics, Boston Scientific, Cardiva Medical Inc., coronavirus, COVID-19, COVID-19 vaccine, GE Healthcare, Haemonetics, Hillrom, Intuitive Surgical, Joe Biden, MedTech 100 Index, Mesa Biotech, Obalon Therapeutics, Philips, Preventice, ReShape Lifesciences, Thermo Fisher Scientific

Thermo Fisher to acquire Mesa Biotech

January 19, 2021 By Nancy Crotti

Thermo Fisher Scientific (NYSE:TMO) today announced it will acquire Mesa Biotech,  a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the transaction. Mesa Biotech has […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Wall Street Beat Tagged With: FDA, Mesa Biotech, Thermo Fisher Scientific

MedTech 100 roundup: Stocks show no signs of slowing down

November 9, 2020 By Sean Whooley

The medtech industry hit further highs in the market last week and the stocks show no sign of stopping their ascent now. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.62 (Nov. 6), marking a 7.3% leap from the 91.01 points registered at the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: BioNTech, coronavirus, COVID-19, Hologic, Inspire Medical Systems Inc., Livongo, MedTech 100 Index, Mesa Biotech, NovoCure, Oxford University, Pfizer, Stryker, Teladoc, transmedics

Mesa Biotech lands $13M to develop rapid COVID/flu test

November 6, 2020 By Sean Whooley

Mesa Biotech announced today that it was awarded $13 million by BARDA to develop its COVID-19 and flu molecular diagnostic. San Diego-based Mesa Biotech received the contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, Mesa Biotech

NIH puts $249m into new COVID-19 tests

July 31, 2020 By Sean Whooley

The National Institutes of Health (NIH) announced today that it is investing $248.7 million in new technologies to address challenges with COVID-19 testing. The “Rapid Acceleration of Diagnostics” (RADx) initiative awarded contracts to seven biomedical diagnostic companies to support lab-based and point-of-care tests that could significantly increase the number, type and availability of tests by […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, Dept. of Health & Human Services (HHS), Fluidigm Corp., Ginkgo Bioworks, Helix OpCo, Mammoth Biosciences, Mesa Biotech, National Institutes of Health (NIH), Quidel Corp., Talis Biomedical

Mesa ships 10,000 COVID-19 rapid tests

April 7, 2020 By Sean Whooley

Mesa Biotech announced today that it is shipping 10,000 of its Accula SARS-CoV-2 molecular rapid point-of-care tests this week for detecting COVID-19. The San Diego-based company’s palm-sized testing platform is designed to enable “near-patient” testing outside a central laboratory with diagnostic results in 30 minutes. Accula uses reverse transcription polymerase chain reaction (RT-PCR) technology to […]

Filed Under: Diagnostics, Featured, Genomics/Molecular Diagnostics Tagged With: coronavirus, COVID-19, Mesa Biotech, National Institutes of Health, U.S. Department of Health and Human Services

Everlywell, Nurx to offer at-home COVID-19 tests

March 19, 2020 By Nancy Crotti

Home testing company Everlywell said today that it will launch a home test kit with telehealth diagnosis for COVID-19 on Monday. The Austin, Texas-based company said it will release 30,000 tests immediately and is working with multiple labs to have testing and diagnosis capacity for a quarter of a million people weekly. Consumers who have […]

Filed Under: Blog Tagged With: 3DMed, coronavirus, CPT Medical, Everlywell, Mesa Biotech, Nurx, Provista Diagnostics, Todos Medical, U.S. Department of Health and Human Services

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS